Tildrakizumab Clears Skin in Most Indian Psoriasis Patients in Phase III Trial
A phase III single-arm trial found that 93.9 percent of Indian patients with moderate-to-severe plaque psoriasis achieved PASI 75 after ...
Tag: CDSCO
A phase III single-arm trial found that 93.9 percent of Indian patients with moderate-to-severe plaque psoriasis achieved PASI 75 after ...
